Senores Pharmaceuticals, Sagility India get Sebi's go ahead to float IPOs
Senores Pharmaceuticals Ltd and Sagility India Ltd, a technology-enabled services provider in the healthcare services space, have received Sebi's go ahead to float their Initial Public Offerings (IPOs), an update with the markets regulator showed on Tuesday.
On the other hand, the regulator has returned the rights issue document of The Bombay Dyeing and Manufacturing Company Ltd , the update showed.
The development from the Securities and Exchange Board of India (Sebi) came a year after the company submitted its draft papers in October 2022 to the regulator proposing to raise Rs 940 crore through the rights issue.
Both Senores Pharmaceuticals and Sagility had filed their respective draft documents in July seeking the regulator's nod to launch IPOs. The regulator's observation was issued on October 9, the update showed.
In Sebi's parlance, obtaining its observations means go-ahead to launch the public issues.
As per the draft paper, Senores Pharmaceuticals' IPO is a combination of